Decoding Genes: Current Update on Radiogenomics of Select Abdominal Malignancies

Area of Science:

• Oncology
• Radiology
• Genetics

Background:

• Technological advances enable genome-wide cancer cell analysis, revealing the genetic basis of malignancies.
• Understanding tumor genetics improves classification, biologic characterization, and targeted therapy discovery.
• Radiogenomics links imaging features with gene mutations and expression patterns.

Purpose of the Study:

• To explore the role of radiogenomics in correlating imaging findings with genetic mutations in various cancers.
• To highlight the potential of imaging biomarkers in predicting treatment response and prognosis.
• To emphasize the importance of radiologists understanding cancer genetics for personalized medicine.

Main Methods:

• Utilizing advanced imaging techniques like multidetector CT, multiparametric MRI, and PET.
• Analyzing genome-wide data from cancer cells.
• Correlating specific imaging features with known gene mutations and expression patterns.

Main Results:

• Specific abdominal malignancies show characteristic imaging features linked to gene mutations.
• Radiogenomic associations are identified in hepatocellular adenomas, liver malignancies, renal cell carcinomas, and pancreatic tumors.
• Imaging characteristics can predict aggressive tumor phenotypes and guide targeted therapies for tumors like GIST.

Conclusions:

• Radiogenomics offers surrogate imaging biomarkers that may complement or supplant genetic tests.
• Familiarity with cancer genetics and imaging biomarkers empowers radiologists in cancer management.
• This field supports personalized treatment strategies and improved patient outcomes.